Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hybrid Closure vs Surgical Repair for Pediatric VSD
NCT02794584Completed
- Sponsor
- Nanjing Medical University
- Start
- Jan 2011
- Primary completion
- Dec 2016
01
Overview
Open-label trial in Ventricular Septal Defect (VSD), sponsored by Nanjing Medical University. Primary endpoints: Cardiac Troponin I at 7 days and Partial Pressure of Oxygen at 7 days. Started Jan 2011; status: completed.
02
Conditions
Ventricular Septal Defect (VSD)
Beyond the preview
Go deeper on NCT02794584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794584.